About Clairvoyant Therapeutics
Clairvoyant Therapeutics is a company based in Vancouver (Canada) founded in 2021 by Thomas Digby was acquired by Psyence Biomed in September 2024.. Clairvoyant Therapeutics has raised $2.35 million across 1 funding round from investors including Psyence Biomed. The company has 11 employees as of December 31, 2024. Clairvoyant Therapeutics operates in a competitive market with competitors including Entheon Biomedical, Nirvana Life Science and Alvarius, among others.
- Headquarter Vancouver, Canada
- Employees 11 as on 31 Dec, 2024
- Founders Thomas Digby
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.35 M (USD)
in 1 rounds
-
Latest Funding Round
$2.35 M (USD), Seed
Nov 30, 2021
- Investors
-
Employee Count
11
as on Dec 31, 2024
-
Acquired by
Psyence Biomed
(Sep 06, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Clairvoyant Therapeutics
Clairvoyant Therapeutics has successfully raised a total of $2.35M through 1 strategic funding round. The most recent funding activity was a Seed round of $2.35 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $2.4M
-
First Round
First Round
(30 Nov 2021)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2021 | Amount | Seed - Clairvoyant Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Clairvoyant Therapeutics
Clairvoyant Therapeutics has secured backing from 1 investor. Prominent investors backing the company include Psyence Biomed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Psilocybin-based psychedelic medicines are developed for therapeutic applications.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Clairvoyant Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Clairvoyant Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Clairvoyant Therapeutics Comparisons
Competitors of Clairvoyant Therapeutics
Clairvoyant Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Entheon Biomedical, Nirvana Life Science and Alvarius, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Psychedelic medicines for addiction disorders are developed and patented.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of opioid addiction
|
|
| domain | founded_year | HQ Location |
Develops bio-pharmaceutical treatments for addiction via psychedelics and therapy.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Clairvoyant Therapeutics
Frequently Asked Questions about Clairvoyant Therapeutics
When was Clairvoyant Therapeutics founded?
Clairvoyant Therapeutics was founded in 2021.
Where is Clairvoyant Therapeutics located?
Clairvoyant Therapeutics is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Is Clairvoyant Therapeutics a funded company?
Clairvoyant Therapeutics is a funded company, having raised a total of $2.35M across 1 funding round to date. The company's 1st funding round was a Seed of $2.35M, raised on Nov 30, 2021.
How many employees does Clairvoyant Therapeutics have?
As of Dec 31, 2024, the latest employee count at Clairvoyant Therapeutics is 11.
What does Clairvoyant Therapeutics do?
Clairvoyant Therapeutics was founded in 2021 and is located in Vancouver, Canada. Focus is placed on the biotechnology sector, where psychedelic-based drugs for addiction therapy are developed and manufactured. Operations involve research into therapeutic applications of psychedelics to address substance use disorders. The company is led by co-founder Thomas Digby, with activities centered on advancing clinical-stage treatments in mental health.
Who are the top competitors of Clairvoyant Therapeutics?
Clairvoyant Therapeutics's top competitors include Entheon Biomedical, Nirvana Life Science and Alvarius.
Who are Clairvoyant Therapeutics's investors?
Clairvoyant Therapeutics has 1 investor. Key investors include Psyence Biomed.